Proposal of the Board of Directors for the appropriation of the available profit
|
in CHF |
|
2023 |
|
2022 |
|
Profit / (loss) for the year |
|
33’551’684 |
|
14’269’773 |
|
Unallocated profit carried forward from previous year |
|
2’861’343 |
|
4’045’272 |
|
Total available profit |
|
36’413’027 |
|
18’315’045 |
|
Appropriation from voluntary retained earnings |
|
– |
|
5’000’000 |
|
Ordinary dividend |
|
–20’390’924 |
|
–20’453’702 |
|
Balance carried forward |
|
16’022’104 |
|
2’861’343 |
|
|
|
|
|
|
|
Dividend distribution per share |
|
|
|
|
|
Gross dividend |
|
0.50 |
|
0.50 |
|
Withholding tax (35%) |
|
–0.18 |
|
–0.18 |
|
Net dividend |
|
0.32 |
|
0.32 |
The Board of Directors proposes the payment of a dividend of CHF 0.50 per share to the Annual General Meeting on April 24, 2024. The company will not pay a dividend on treasury shares held by medmix Ltd or one of its subsidiaries.